Additionally, Compound Bitter Ginseng Injection enhances hepatocellular carcinoma sensitivity to sorafenib through attenuation of TAMs-mediated immunosuppression via TNFR1 signaling (37). The gene discussed is TNFRSF1A; the disease is hepatocellular carcinoma.